Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C Shows Liver Fibrosis Regression on Three Noninvasive Tests: A Puerto Rican Cohort.

MLA

López-Marte, Paola, et al. “Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C Shows Liver Fibrosis Regression on Three Noninvasive Tests: A Puerto Rican Cohort.” Puerto Rico Health Sciences Journal, vol. 43, no. 3, Sept. 2024, pp. 145–50. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=39269766&authtype=sso&custid=ns315887.

APA

López-Marte, P., Goyco-Cortés, B., & Rosado-Carrión, B. (2024). Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C Shows Liver Fibrosis Regression on Three Noninvasive Tests: A Puerto Rican Cohort. Puerto Rico Health Sciences Journal, 43(3), 145–150.

Chicago

López-Marte, Paola, Bianca Goyco-Cortés, and Bárbara Rosado-Carrión. 2024. “Direct-Acting Antiviral Therapy in Patients with Chronic Hepatitis C Shows Liver Fibrosis Regression on Three Noninvasive Tests: A Puerto Rican Cohort.” Puerto Rico Health Sciences Journal 43 (3): 145–50. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=39269766&authtype=sso&custid=ns315887.